Radiopharmaceutical Supply – Therapeutic Isotopes

The contract pertains to the supply of therapeutic radioactive isotopes, specifically I-131 and Lu-177, in exact millicurie quantities required for clinical treatment protocols. The supplier must ensure compliance with all applicable regulatory standards for radiopharmaceutical production, handling, and delivery, with an emphasis on maintaining product purity, potency, and sterility to meet medical safety requirements. Emergency delivery capabilities are essential, as timely access to these isotopes is critical for patient care, particularly in oncology and nuclear medicine applications where dosing schedules are time-sensitive. This subcontract is issued under the Department of Veterans Affairs through the 250-NETWORK Contract Office 10, with performance designated at Ann Arbor, Michigan, 48105. The solicitation was posted on May 6, 2026, and responses are due by May 20, 2026, at 8:30 PM Eastern Time. The applicable NAICS code is 325412, which classifies the operation under Pharmaceutical and Medicine Manufacturing, reflecting the specialized nature of radiopharmaceutical production. All parties must adhere to the technical, logistical, and regulatory expectations outlined to ensure seamless integration into VA healthcare delivery systems.